Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 822 across all filing types
Latest filing 2014-05-08 Regulatory Filings
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Report of Periodic or Interim Report
Regulatory Filings
2014-05-08 Hebrew (modern)
Report of Periodic or Interim Report
Report Publication Announcement Classification · 1% confidence The document explicitly states it is a 'Report of Periodic or Interim Report' under Israeli regulations. Crucially, it mentions 'Attached hereto is a report on *CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2014*'. Since the document itself is short (1601 chars) and serves primarily to announce the availability of the actual financial statements (the PDF file mentioned), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive Interim Report (IR) itself. The date March 31, 2014, indicates a period shorter than a year, which aligns with an interim report, but the filing mechanism here is the announcement.
2014-05-08 English
Immediate Report
Regulatory Filings
2014-05-08 Hebrew (modern)
Immediate Report
Earnings Release Classification · 1% confidence The document is an 'Immediate Report' filed by KAMADA LTD, referencing the 'Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. Crucially, the text states: 'Attached hereto is a report on *Kamada Reports First Quarter of 2014 Financial Results* *050814_KMDA_1Q14_financial_results_FINAL_isa.pdf*'. This structure—a brief regulatory filing announcing the publication of a specific financial report (First Quarter 2014 Financial Results)—fits the definition of a Report Publication Announcement (RPA). It is not the full Interim Report (IR) itself, but the announcement of its release, and the document length is very short (1605 chars), adhering to the 'MENU VS MEAL' rule. Q1 2014
2014-05-08 English
Immediate Report
Regulatory Filings
2014-04-24 Hebrew (modern)
Immediate Report
Report Publication Announcement Classification · 1% confidence The document is an 'Immediate Report' filed by KAMADA LTD, referencing the 'Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. The core content states: 'Attached hereto is a report on *Kamada Announces Significantly Improved Infusion Rate for Glassia* *KMDA_Form_6K_-_Improved_Infusion_Rate_isa.pdf*'. This structure—a brief announcement stating that a specific report (in this case, likely a Form 6-K equivalent filing, which is an immediate report for foreign issuers) is attached or published—fits the definition of a Report Publication Announcement (RPA). The document itself is short (1614 chars) and serves to notify the market about the release of the detailed information, rather than being the detailed report itself. Since RPA is specifically for announcements of report publication, it is the most appropriate classification over RNS or the underlying report type.
2014-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.